GlassScriptPhysician profile
Shelley Yang
NPI 1386120822
$3,732.00
in general payments reported to CMS, 2019-2025
9 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,515 · 2020: $11.03 · 2021: $726 · 2022: $16.65 · 2023: $1,150 · 2024: $120 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,005 · Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,005.01 |
| Food and Beverage | $458.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,298.54 | 2023-2025 | |
| Patterson Companies, INC. | $750.00 | 2019 | |
| Sirona Dental, INC. | $750.00 | 2019 | |
| Dentsply Sirona INC | $650.44 | 2021-2025 | Astra Tech Implant System, Cavitron |
| Biohorizons Implant Systems INC. | $132.37 | 2021-2023 | Biohorizons |
| Align Technology, INC. | $76.43 | 2024 | Invisalign |
| Voco America INC. | $44.56 | 2020-2025 | Admira Fusion, Grandio So, Ionoseal |
| Coltene Whaledent INC. | $14.96 | 2021 | |
| 3m Company | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.